PEX: BPC Statistics

Total Valuation

Birzeit Pharmaceuticals Company has a market cap or net worth of JOD 106.25 million. The enterprise value is 97.58 million.

Market Cap	106.25M
Enterprise Value	97.58M

Important Dates

The next estimated earnings date is Thursday, February 13, 2025.

Earnings Date	Feb 13, 2025
Ex-Dividend Date	Apr 24, 2024

Share Statistics

Birzeit Pharmaceuticals Company has 38.76 million shares outstanding. The number of shares has increased by 1.00% in one year.

Current Share Class	n/a
Shares Outstanding	38.76M
Shares Change (YoY)	+1.00%
Shares Change (QoQ)	-2.10%
Owned by Insiders (%)	23.26%
Owned by Institutions (%)	n/a
Float	23.90M

Valuation Ratios

The trailing PE ratio is 41.24.

PE Ratio	41.24
Forward PE	n/a
PS Ratio	3.88
PB Ratio	1.49
P/TBV Ratio	1.52
P/FCF Ratio	38.04
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 18.24, with an EV/FCF ratio of 34.93.

EV / Earnings	38.54
EV / Sales	3.62
EV / EBITDA	18.24
EV / EBIT	22.48
EV / FCF	34.93

Financial Position

The company has a current ratio of 7.02

Current Ratio	7.02
Quick Ratio	5.54
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	605.62

Financial Efficiency

Return on equity (ROE) is 3.47% and return on invested capital (ROIC) is 3.69%.

Return on Equity (ROE)	3.47%
Return on Assets (ROA)	3.11%
Return on Capital (ROIC)	3.69%
Revenue Per Employee	89,598
Profits Per Employee	8,439
Employee Count	300
Asset Turnover	0.31
Inventory Turnover	1.95

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -8.70% in the last 52 weeks. The beta is 0.02, so Birzeit Pharmaceuticals Company's price volatility has been lower than the market average.

Beta (5Y)	0.02
52-Week Price Change	-8.70%
50-Day Moving Average	3.83
200-Day Moving Average	4.02
Relative Strength Index (RSI)	48.12
Average Volume (20 Days)	19,642

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Birzeit Pharmaceuticals Company had revenue of JOD 26.88 million and earned 2.53 million in profits. Earnings per share was 0.07.

Revenue	26.88M
Gross Profit	9.10M
Operating Income	4.33M
Pretax Income	3.08M
Net Income	2.53M
EBITDA	5.33M
EBIT	4.33M
Earnings Per Share (EPS)	0.07

Full Income Statement

Balance Sheet

Cash & Cash Equivalents	9.15M
Total Debt	n/a
Net Cash	9.15M
Net Cash Per Share	0.24
Equity (Book Value)	70.56M
Book Value Per Share	1.83
Working Capital	40.31M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 3.68 million and capital expenditures -884,525, giving a free cash flow of 2.79 million.

Operating Cash Flow	3.68M
Capital Expenditures	-884,525
Free Cash Flow	2.79M
FCF Per Share	0.07

Full Cash Flow Statement

Margins

Gross margin is 33.86%, with operating and profit margins of 16.09% and 9.42%.

Gross Margin	33.86%
Operating Margin	16.09%
Pretax Margin	11.47%
Profit Margin	9.42%
EBITDA Margin	19.83%
EBIT Margin	16.09%
FCF Margin	10.39%

Dividends & Yields

This stock pays an annual dividend of 0.04, which amounts to a dividend yield of 1.30%.

Dividend Per Share	0.04
Dividend Yield	1.30%
Dividend Growth (YoY)	-50.08%
Years of Dividend Growth	n/a
Payout Ratio	54.18%
Buyback Yield	-1.00%
Shareholder Yield	0.29%
Earnings Yield	2.38%
FCF Yield	2.63%

Dividend Details

Stock Splits

The last stock split was on April 21, 2022. It was a forward split with a ratio of 2.

Last Split Date	Apr 21, 2022
Split Type	Forward
Split Ratio	2

Scores

Birzeit Pharmaceuticals Company has an Altman Z-Score of 6.03.

Altman Z-Score	6.03
Piotroski F-Score	n/a